Logo

Cipla Ltd. Share Price

Pharmaceuticals & Drugs

Cipla Ltd. (INR)1550.18.6   (0.6%)

Exchange ScripsBSE500087NSECIPLAISININE059A01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Cipla Ltd. Performance

Market performance

Open price1542
High1570.8
Volumes2315010
Prev Close1550.1
Low1538
Closing date2025-04-30

Historical performance

1 Year High1702.05
3 Year High1702.05
5 Year High1702.05
1 Year Low1317.25
3 Year Low852.00
5 Year Low565.60

Cipla Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
125342
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
30.36
Dividend Yield
Dividend Yield
0.42 %

Cipla Ltd. Investment Returns

1 Year
10.7%
3 Years
58%
5 Years
162.9%
10 Years
143.7%

Cipla Ltd. Technicals

IndicatorsValueSignal
5-DMA1544.86Bullish
10-DMA1530.89Bullish
20-DMA1486.82Bullish
50-DMA1475.74Bullish
100-DMA1470.78Bullish
200-DMA1519.49Bullish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters44668
Foreign Investors22222
Domestic Investors22446
Public Investors543415525109470227463562436145
Government22221

Cipla Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income7466512132172698
Operating Profit70376550244833745184
Interest899109510631607
Depreciation10510117211051910677
Profit Before Tax57019403843493332901
Consolidated Net Profit41215280192516824049
Adjusted EPS51353130

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1615161416141613
Total Reserves264584231845206363181232
Minority Interest959305827572591
Total Non-Current Liabilities8191835621716601
Total Liabilities321300290067266523248372
Capital Work in Progress8643689238295708
Total Assets321300290067266523248372

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities41339323763325937552
Cash Flow from Investing Activities-29880-23885-18719-23872
Cash Flow from Financing Activitie-12004-9583-15998-12395
Net Cash Inflow / Outflow-545-1092-14581285
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 30.36.
  • 3Y Stock Price CAGR of the stock is 16.6.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹70376 Million.
  • The company generated revenue of ₹257741 Million in the previous financial year.

Cipla Ltd.

1550.18.6   (0.6%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1091581.3
No. of Shares: 704.2
Performance:9.2%
P/L: ₹91581.3

Top Gainers

SymbolChange%
SONATSOFTW421.55(12%)
ABINFRA88.96(11%)
VMM118.48(10%)
JETFREIGHT14.77(10%)
GLOBALVECT220.9(10%)

Top Losers

SymbolChange%
PREMEXPLN416.2(-11%)
PRAJIND461.3(-9%)
GTECJAINX25.6(-9%)
MADHUCON6.85(-8%)
AMBICAAGAR26.8(-8%)
GSS37.6(-8%)
OSWALAGRO78.03(-8%)
WALCHANNAG180.82(-8%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

60.1

53.65

March 30 - April 30

Hester Biosciences Ltd.

42.1

1782.9

March 30 - April 30

Sakar Healthcare Ltd.

28.3

271.56

March 30 - April 30

Valiant Laboratories Ltd.

25.9

96.4

March 30 - April 30

Morepen Laboratories Ltd.

25.8

60.17

March 30 - April 30

Panacea Biotec Ltd.

25.1

552.15

March 30 - April 30

Brooks Laboratories Ltd.

24.2

132.1

March 30 - April 30

Bal Pharma Ltd.

21.8

102.15

March 30 - April 30

Announcing Stock of the Month!

Stock of the Month
Stock of the Month